Literature DB >> 1356851

A randomized controlled trial of valethamate bromide in acceleration of labor.

S Kuruvila1, P Jasper, A Peedicayil, M Mathai.   

Abstract

A randomized controlled study of valethamate bromide administered by intramuscular injection in acceleration of labor was done in 60 consecutive primigravidae and 60 consecutive multigravidae admitted in labor at 2-4 cm cervical dilatation. There was no difference observed in the rate of cervical dilatation between those who received valethamate bromide and those who received normal saline. However, maternal tachycardia was observed in significantly more women primigravida RR 1.97, 95% CI 1.3-3.0; multigravida RR 2.16, 95% CI 1.3-3.6) who had received valethamate bromide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356851     DOI: 10.1016/0020-7292(92)90042-h

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

Review 1.  Antispasmodics for labour.

Authors:  Anke C Rohwer; Oswell Khondowe; Taryn Young
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 2.  Effectiveness and Safety of Camylofin in Augmentation of Labor: A Systematic Review and Meta-Analysis.

Authors:  Nandita Palshetkar; Ameya Purandare; Hemant Mehta; Rohan Palshetkar
Journal:  J Obstet Gynaecol India       Date:  2020-08-11

3.  Valethamate bromide: Conflicting evidence and continuing use.

Authors:  Thirunavukkarasu Arun Babu; Vijayan Sharmila
Journal:  J Pharmacol Pharmacother       Date:  2010-07

4.  Valethamate bromide: Is there any proof of efficacy and safety for its use in labor?

Authors:  B Gitanjali
Journal:  J Pharmacol Pharmacother       Date:  2010-01

5.  Quality of Labor Epidural Analgesia and Maternal Outcome With Levobupivacaine and Ropivacaine: A Double-Blinded Randomized Trial.

Authors:  T Senthil Kumar; P Rani; V R Hemanth Kumar; Sunita Samal; S Parthasarathy; M Ravishankar
Journal:  Anesth Essays Res       Date:  2017 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.